Category Archives: HIV care & treatment

FDA accepts two new drug applications for new NNRTI doravirine

The Food and Drug Administration has accepted two new drug applications (NDAs) for the HIV medication called doravirine. Doravirine is a new NNRTI or non-nucleoside reverse transcriptase inhibitor that completed two 48-week studies in 2017. If both NDAs are approved, doravirine could be available this year…Read More

Congratulations to New Program Directors, David Evans and Emalie Huriaux

Project Inform has a small and mighty group of staff — seven in total — who develop and implement our programs in three areas: research advocacy, education and public policy. Anne Donnelly has served as our Director of Health Care Policy for 10 years, leading our…Read More

Gilead will end Atripla Copay Assist Card program, transition to Advancing Access by January 1, 2018

Gilead recently announced that they are ending the BMS3assist Co-Pay Assist Card program for Atripla (efavirenz + emtricitabine + tenofovir) on December 31, 2017. For anyone who is currently enrolled in this Atripla program and in need of copay assistance for the medication, they should enroll in…Read More

Republican tax bill strips health coverage away from 13 million Americans

#ProtectOurCareHIVHCV The Senate tax bill decimates our health care. Democrats are being left out of the process. Call Republican Senators today and tell them to vote NO! ACTION: The tax measure adds billions to the federal deficit and will require steep cuts to health care programs. Republicans want…Read More

FDA approves new two-drug, single tablet Juluca for people with well controlled HIV

On November 21, 2017, the Food and Drug Administration approved a new two-drug, combination pill to treat HIV infection in people whose viral loads are already well controlled on another regimen. The once-a-day medication, called Juluca, is a combination of the integrase inhibitor dolutegravir (Tivicay) and…Read More

Project Inform’s Dana Van Gorder highlighted in World AIDS Day video from Quest

As World AIDS Day approaches this year on December 1, 2017, Quest Diagnostics has released a new video recognizing the profound difference that many organizations and individuals are making in the fight to end AIDS. Highlighted in the video is Project Inform’s executive director Dana Van…Read More

Covered California Frequently Asked Questions

For People Living with HIV and Hepatitis C and People Considering PrEP Covered California open enrollment begins today November 1, 2017 and continues through January 31, 2018. However, there may be some confusion about how the current Administration’s actions may impact your health care. The California HIV/AIDS…Read More